Lieberman health staffer resigns
Sen. Joseph Lieberman (D-Conn.) Counsel Chuck Ludlam will leave Capitol Hill in late June to serve as a Peace Corps volunteer in Senegal. Ludlam was involved in developing the "Bioshield" bill enacted in 2004 and Lieberman's version of "Bioshield II" (S 975), introduced on April 28 (1"The Pink Sheet" May 9, 2005, p. 23). Before joining Lieberman's office, Ludlam was the Biotechnology Industry Organization's VP-government affairs...
You may also be interested in...
Manufacturers who enter into biodefense contracts must notify the government within 180 days which patent would be covered by a potential "wild card" extension under the final version of "BioShield II" legislation from Sens. Orrin Hatch (R-Utah), Joe Lieberman (D-Conn.) and Sam Brownback (R-Kan.)
A lack of regulatory harmonization for dietary supplements in Asia is a big challenge facing companies operating in the region, according to experts from the Asia Regulatory Professionals Association. The ARPA is looking to start a conversation on the issue which the association hopes will lead to regulatory change.
The Chinese Society of Clinical Oncology (CSCO) annual meeting, against the background of the global pandemic, has one clear message that local researchers and players are pressing ahead to take a leadership role in cutting-edge cancer research globally.